New publication by NFCR-supported scientist Rakesh Jain, Ph.D., applies cancer research findings to help COVID-19 treatment in different patient groups. Few drugs for COVID-19 appear to work well in unselected patients, but now a new mathematical model provides insight into which patients benefit from which treatments. Researchers and investigators, including…...
Biosimilar Drugs: Lowering the Cost of Cancer Care?
The National Foundation for Cancer Research (NFCR) answers some of the most frequently asked questions about biosimilar drugs for cancer treatment. Biologic drugs (biologics) are a special class of medications that are made from living organisms, such as proteins.1 Vaccines, hormones, and anti-allergy medications are all examples of biologics.2 These…...
Childhood Cancer Treatment by NFCR Partner Receives Fast Track Review and More Good News From the FDA
Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, recently announced that the Unites States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) to volasertib, one of its drugs. Volasertib is a small molecular inhibitor that has been…...
NFCR-Supported Researcher Leads Study Aiming to Understand Which Patients May Respond Best to Immunotherapy
New approach developed by Dr. Rakesh Jain and his research team identifies biomarkers that may indicate which patients will best respond to immune checkpoint blockade therapies. A research team led by NFCR-supported scientist Rakesh K. Jain, PhD, the Andrew Werk Cook Professor of Tumor Biology at Harvard Medical School and…...
Mastectomy and Breast Reconstruction: What Breast Cancer Patients Should Know
Mastectomy is just one of the treatment options available to breast cancer patients. Learn more about what to expect before, during, and after the procedure, as well as some tips to help you prepare. A breast cancer diagnosis can be devastating, and navigating potential treatment options can be stressful and…...
Project Patient Voice – Helping Patients in the Fight Against Cancer
The U.S. Food and Drug Administration (FDA) recently launched a new initiative aimed to help patients in the fight against cancer. This project, appropriately named Project Patient Voice, was initiated by the FDA’s Oncology Center of Excellence to give patients and health care professionals unique information that has not been publicly…...
Treating Cancer During COVID-19: Nicole’s Story
The COVID-19 pandemic has brought the world to its knees, preventing many events from taking place and closing the doors of uncountable businesses. People across the world were advised to stay inside and only leave the house for necessities. At first it was strange, uncomfortable, and scary. As time moved…...
DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083’s Participation in a Pivotal Study for Glioblastoma Sponsored by the Global Coalition for Adaptive Research
SAN DIEGO, June 24, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today it has received a $500,000 loan from the National Brain Tumor Society (NBTS) and the National Foundation for Cancer…...
Strategic Media Partner
